Wockhardt – A story with twist and turn

Hello Everyone,
First of all, kudos on such great research on this topic. It is definitely quite insightful!
I had some questions regarding this sector. Coming from a non-science background, they might be a little basic but would really be helpful for me to delve deeper into this topic.

1. What is the next stage after the Clinical trials are done? And what might be the success rate of a drug clearing Phase III of these trials?
2. After the drug has received FDA approval, what shall be next step? Will the innovator company manufacture this drug on its own, or outsource/license other companies? How much % of revenue oppurtunity could Wockhardt have from the total market of this drug?
3. What could be the timeline for this drug (WCK 5222) to be in the market, my assumption is atleast 2 years. But since it is being used on humanitarian grounds already, can we expect the authorities to expedite the approval process?
   Thankyou so much!